Results 101 to 110 of about 1,747,741 (337)

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Characterization and Processing of Phosphate Rock as a Raw Material for Potential Use as Biomaterials

open access: yesCiencia e Ingeniería Neogranadina
Seventy-five percent of the phosphate rock extracted is used for the production of phosphoric acid. However, during the leaching process, it is also possible to dissolve calcium compounds, allowing for the extraction of phosphorus and calcium ions from ...
Gloria Soto Calle   +3 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

New Na+,Mg2+,Zn2+ -containing hydroxyapatite/ZrO2 composites: preparation, mechanic properties and cytotoxicity

open access: yesBMC Chemistry
Firstly apatite-type carbonated calcium phosphate and biphasic calcium phosphates (mixture of phases based on Ca10(PO4)6(OH)2 and β-Ca3(PO4)2 with weight ratio 60 : 40%) which contained the trace elements complex (Na+, Mg2+, Zn2+) were obtained from ...
N. Strutynska   +6 more
doaj   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Phase transitions in calcium phosphates.

open access: yes, 2023
Most people have some diseases, bones injuries and their deformations. Scientists are trying to synthesize synthetic materials which could be used in bone regeneration.
Griesiūtė, Diana,
core  

Progress on the preparation of nanocrystalline apatites and surface characterization: Overview of fundamental and applied aspects [PDF]

open access: yes, 2013
Nanocrystalline calcium phosphate apatites constitute the main inorganic part of hard tissues, and a growing focus is devoted to prepare synthetic analogs, so-called “biomimetic”, able to precisely mimic the morphological and physico-chemical features of
Iafisco, Michele   +5 more
core   +1 more source

Calcium phosphates and silicon: exploring methods of incorporation

open access: yesBiomaterials Research, 2017
Background Bioinorganics have been explored as additives to ceramic bone graft substitutes with the aim to improve their performance in repair and regeneration of large bone defects.
Ana I. Rodrigues   +4 more
doaj   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy